Targeting RRM2 with dual-modal theranostic smart nanoresponder overcomes osimertinib resistance and triggers immune remodeling in NSCLC
利用双模式诊疗智能纳米应答器靶向RRM2可克服奥希替尼耐药性并触发非小细胞肺癌的免疫重塑
期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.ady7930
Zhu, Jinyu; Cui, Kaihui; Zhou, Wenyuan; Zhou, Xin; Yao, Yuan; Zhao, Chuanke; Yang, Yuwen; Liu, Yang; Tao, Jinping; Yang, Zhi; Zhu, Hua; Tang, Bufu; Li, Nan